Category:
Anti-tumor Preparations
Standard:
N;
Bortezomib for Injection is is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. It is used for the treatment of relapsed multiple myeloma and mantle cell lymphoma.